Open Access. Powered by Scholars. Published by Universities.®
Treat and Extend Regimen;; anatomical classification;; choroidal neovascularization;; fluorescein angiography classification;; intravitreal anti-VEGF injections;; neovascular age-related macular degeneration
Articles 1 - 1 of 1
Full-Text Articles in Ophthalmology
Long-Term Visual Outcomes For A Treat And Extend Anti-Vascular Endothelial Growth Factor Regimen In Eyes With Neovascular Age-Related Macular Degeneration, S. Mrejen, J. J. Jung, C. Chen, S. N. Patel, R. Gallego-Pinazo, L. A. Yannuzzi, L. Xu, M. Marsiglia, S. Boddu, K. B. Freund
Long-Term Visual Outcomes For A Treat And Extend Anti-Vascular Endothelial Growth Factor Regimen In Eyes With Neovascular Age-Related Macular Degeneration, S. Mrejen, J. J. Jung, C. Chen, S. N. Patel, R. Gallego-Pinazo, L. A. Yannuzzi, L. Xu, M. Marsiglia, S. Boddu, K. B. Freund
Journal Articles
With the advent of anti-vascular endothelial growth factor (VEGF) therapy, clinicians are now focused on various treatment strategies to better control neovascular age-related macular degeneration (NVAMD), a leading cause of irreversible blindness. Herein, we retrospectively reviewed consecutive patients with treatment-naive NVAMD initially classified based on fluorescein angiography (FA) alone or with an anatomic classification utilizing both FA and optical coherence tomography (OCT) and correlated long-term visual outcomes of these patients treated with an anti-VEGF Treat-and-Extend Regimen (TER) with baseline characteristics including neovascular phenotype. Overall, 185 patients (210 eyes) were followed over an average of 3.5 years (range 1-6.6) with a …